-
[文献書誌] Nakahara H, et al.: "Anti-interleukin-6 receptor antibody therapy reduces vascular endotherlial growth factor (VEGF) production in rheumatoid arthritis"Arthritis Rheum.. 48. 1521-1529 (2003)
-
[文献書誌] Nishimoto N. et al.: "Toxicity, pharmacokinetics, and dose finding study of repetitive treatment with humanized anti-interleukin 6 receptor antibody, MRA, in rheumatoid arthritis -a phase I/II clinical study of MRA for rheumatoid arthritis in Japan-"J.Rheum.. 30. 1426-1435 (2003)
-
[文献書誌] Hagihara K, et al.: "IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system"Biochem.Biophys.Res.Commun.. 314. 363-369 (2004)
-
[文献書誌] Ito A, et al.: "A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibodyin active Crohn's disease"Gastroenterology. (in press). (2004)
-
[文献書誌] Mihara M, et al.: "Anti-interleukin-6 receptor antibody inhibits murine AA-amyloidosis"J.Rheum.. (in press). (2004)
-
[文献書誌] Ohno S, et al.: "Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in clinical study on Behcet's disease with refractory uveoretinitis"J.Rheum.. (in press). (2004)